Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Palliative care for patients with cancer: what are the educational needs of community pharmacists?

Hussainy SY, Beattie J, Nation RL, Dooley MJ, Fleming J, Wein S, Pisasale M, Scott WJ, Marriott JL.

(2006), Support Care Cancer, 14(2), 177-84

Generic medicines: perceptions of general practitioners in Melbourne, Australia

Hassali MA, Kong DC, Stewart K

(2006), J Generic Medicine, 3(3), 214-25

Generic medicines perceptions of community pharmacists in Melbourne, Australia

Hassali MA, Kong DC, Stewart K

(2006), J Pharma Finance, Economics and Policy, 14(3), 27-45

Medication regimen complexity and adherence in patients at risk of medication misadventure

George J, Vuong T, Bailey MJ, Kong DC, Marriott JL, Stewart K

(2006), J Pharm Pract Res, 36(2), 99-102

Development and validation of the medication-based disease burden index

George J, Vuong T, Bailey MJ, Kong DC, Marriott JL, Stewart K

(2006), Ann Pharmacother, 40(4), 645-50

Development and validation of the Beliefs and Behaviour Questionnaire (BBQ)

George J, Mackinnon A, Kong DC, Stewart K

(2006), Patient Education and Counseling, 64(1-3), 50-60

Smoking Cessation: COPD Patients’ Perspective

George J, Kong DC, Santamaria NM, Ioannides-Demos LL, Stewart K

(2006), J Pharm Pract Res, 36(2), 107-10

Adherence to diseases management interventions for COPD patients: patient’s perspective

George J, Kong DC, Santamaria NM, Ioannides-Demos LL, Stewart K

(2006), J Pharm Pract Res, 36(4), 278-86

Proprietary names for glaucoma drugs: potential for error

Dooley M, Van de Vreede M

(2006), Lancet, 368(9545), 1419-20

Taking aim at infusion confusion

Burdeu G, Crawford R, van de Vreede M, McCann J

(2006), J Nurs Care Qual, 21(2), 151-9

Evaluation of sympathetic re-innervation in heterotopic cardiac transplants by iodine-123-metaiodobenzylguanidine (I-123-MIBG) imaging

Yap KS, Gould P, Kalff V, Kaye DM, Esmore D, Kelly MJ

(2006), J Heart Lung Transplant, 25(8), 977-80

Focal MIBI uptake is a better indicator of active myeloma than diffuse uptake

Nandurkar D, Kalff V, Turlakow A, Spencer A, Bailey MJ, Kelly MJ

(2006), Eur J Haematol, 76(2), 141-6

Findings on 18F-FDG PET scans after neoadjuvant chemoradiation provides prognostic stratification in patients with locally advanced rectal carcinoma subsequently treated by radical surgery

Kalff V, Duong C, Drummond EG, Matthews JP, Hicks RJ

(2006), J Nucl Med, 47(1), 14-22

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide

Cebon J; Australasian Gastro-Intestinal Trials Group (AGITG) Ag0001H Investigators

(2006), Br J Cancer, 95(7), 853-61

An international multicenter study evaluating the impact of an alternative biochemical failure definition on the judgment of prostate cancer risk

Williams SG, Duchesne GM, Gogna NK, Millar JL, Pickles T, Pratt GR, Turner S

(2006), Int J Radiat Oncol Biol Phys, 65(2), 351-7

Management of glioma in Victoria (1998-2000): retrospective cohort study

Rosenthal MA, Drummond KJ, Dally M, Murphy M, Cher L, Ashley D, Thursfield V, Giles GG

(2006), Med J Aust, 184(6), 270-3

Does chemotherapy improve survival in high-risk stage I and II Merkel cell carcinoma of the skin?

Poulsen MG, Rischin D, Porter I, Walpole E, Harvey J, Hamilton C, Keller J, Tripcony L

(2006), Int J Radiat Oncol Biol Phys, 64(1), 114-9

Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma

Ng M, Wirth A, Ryan G, MacManus M, Davis S

(2006), Australas Radiol, 50(3), 222-7

Disease-specific quality of life among patients with localized prostate cancer: an Australian perspective

Newton FJ, Burney S, Millar JL, Frydenberg M, Ng KT

(2006), BJU Int, 97(6), 1179-83

Alternative explanations for T-cell response to in-situ gene therapy for prostate cancer: in reply to Fujita et al. (Int J Radiat Oncol Biol Phys 2006;65:84-90)

Millar JL, Sutherland JS, Boyd RL.

(2006), Int J Radiat Oncol Biol Phys, 66(5), 1599

698 699 700 701 702